Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1
CompletedOBSERVATIONAL
Enrollment
22
Participants
Timeline
Start Date
March 17, 2021
Primary Completion Date
October 17, 2021
Study Completion Date
October 17, 2021
Conditions
Lung Cancer ROS Translocated
Trial Locations (1)
94000
CHI Créteil, Créteil
All Listed Sponsors
lead
Centre Hospitalier Intercommunal Creteil
OTHER
NCT04718012 - Retrospective, Observational, Multi-center Study Evaluating the Efficacy and Tolerance of Brigatinib in the Management of Rearranged CBNPC ROS1 | Biotech Hunter | Biotech Hunter